» Articles » PMID: 3515313

Quinolones in the Treatment of Gonorrhoea and Chlamydia Trachomatis Infections

Overview
Specialty Pharmacy
Date 1986 Feb 21
PMID 3515313
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

123 Female patients suffering from uncomplicated urogenital gonorrhoea were treated with either 200 mg or 400 mg enoxacin. The cure rate in the 400 mg group was 100%; the cure rate in the 200 mg group was 95.7% 212 Male patients suffering from urethral gonorrhoea were treated with either 250 mg or 500 mg ciprofloxacin (one tablet). Cure rates in both groups were 100%. Post-gonococcal urethritis was observed in 31 out of 85 (36%) patients in the first, and 21 out of 79 (27%) in the second group. In a pilot study 42 male patients suffering from non-gonococcal urethritis were treated during one week with I g ciprofloxacin daily. In 22 patients Chlamydia trachomatis was isolated from the urethra: in 20 of these 22 cases Chlamydia trachomatis could not be cultured after treatment (cure rate 91%), but in 4 of these 20 cases (20%) and in 8 of the 20 Chlamydia trachomatis negative cases (40%) urine-sediment abnormalities were present after treatment.

Citing Articles

Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.

Paez-Canro C, Alzate J, Gonzalez L, Rubio-Romero J, Lethaby A, Gaitan H Cochrane Database Syst Rev. 2019; 1:CD010871.

PMID: 30682211 PMC: 6353232. DOI: 10.1002/14651858.CD010871.pub2.


In vitro activity and mode of action of fluoroquinolones.

Verbist L Pharm Weekbl Sci. 1987; 9 Suppl:S2-10.

PMID: 3438148 DOI: 10.1007/BF02075251.


Worldwide clinical data on efficacy and safety of ciprofloxacin.

Schacht P, ARCIERI G, Branolte J, Bruck H, Chysky V, Griffith E Infection. 1988; 16 Suppl 1:S29-43.

PMID: 3286511 DOI: 10.1007/BF01650504.


Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males.

van der Willigen A, Polak-Vogelzang A, Habbema L, Wagenvoort J Eur J Clin Microbiol Infect Dis. 1988; 7(5):658-61.

PMID: 3143576 DOI: 10.1007/BF01964246.


Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Paton J, Reeves D Drugs. 1988; 36(2):193-228.

PMID: 3053126 DOI: 10.2165/00003495-198836020-00004.

References
1.
Reeves D, Bywater M, HOLT H . The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity. J Antimicrob Chemother. 1984; 14 Suppl C:7-17. DOI: 10.1093/jac/14.suppl_c.7. View

2.
Loo P, Ridgway G, Oriel J . Single dose ciprofloxacin for treating gonococcal infections in men. Genitourin Med. 1985; 61(5):302-5. PMC: 1011843. DOI: 10.1136/sti.61.5.302. View

3.
Stolz E, Zwart H, Michel M . Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam. Br J Vener Dis. 1974; 50(3):202-7. PMC: 1045016. DOI: 10.1136/sti.50.3.202. View

4.
Chin N, Neu H . In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother. 1983; 24(5):754-63. PMC: 185938. DOI: 10.1128/AAC.24.5.754. View

5.
Notowicz A, Stolz E, van Klingeren B . A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea. J Antimicrob Chemother. 1984; 14 Suppl C:91-4. DOI: 10.1093/jac/14.suppl_c.91. View